Her other biochemical tests were in normal ranges except Troponin: 1,1 and CK-MB: 94. His chest pain continued decreasingly. He was hospitalized to Coronary ICU, his coronary angiography was in normal ranges. Nonsteroidal anti-inflammatory drug and amoxicillin-clav- ulanate were added to treatment for myocarditis. He was discharged with full recovery after 6 days. Conclusion: Emergency physicians must be aware that patients with scorpion bites can admit to ED with chest pain, and scorpion bites can cause life-threatening conditions such as anaphylaxis, myocarditis, acute coronary syndrome etc. - PP-060 Relation of the Worsening Renal Function with the Thirty- Day Mortality in Patients with the Non ST-Segment Elevation Myocardial Infarction. Selçuk Yazıcı 1 , Ays ¸e Emre 1 , Ufuk Sadık Ceylan 1 , Aysun Erdem 1 , Sait Terzi 1 , S ¸ükrü Akyüz 1 , Adnan Kaya 1 , Cevdet Dönmez 2 , Zehra Antep 3 , Emrah Bozbeyo glu 1 , Özlem Yıldırımtürk 1 , Kemal Yes ¸ilçimen 1 . 1 Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Cardiology Clinic, Istanbul; 2 Artvin State Hospital, Cardiology Clinic, Artvin; 3 Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Department of Diagnosis Related Group, Istanbul. Background: Preexisting renal insufficiency is a strong predictor of cardiovascular mortality and morbidity in patients admitted with acute coronary syndrome. The prognostic significance of worsening renal function has also been shown in various cohorts of cardiac diseas. However, the thirty-day prognostic importance of worsening renal function in the patients with non-ST elevation myocardial infarction (NSTE-MI) is not well documented. Methods: We prospectively analyzed 387 consecutive patients with NSTE-MI. Worsening renal function was defined as a 25% or more decrease in estimated GFR (eGFR) during of hospitalization period. We have categorized the patients in two groups; worsening and without worsening group. Baseline demographics, clinical feature, angiographic findings, receival of invasive treatment, and thirty day mortality were compared. Additionally, we performed multivariate analysis for thirty day mortality. Results: Mean age of patients were 63Æ13 years (67%, male). Worsening renal function ocuured in 47 (12%) patients, who were older and had more cerebrovascular disease (67Æ12 vs 63Æ13, p¼0.032 and 15% vs 7%, p¼0.40). But other risc factors of coronary artery diseas were similar among the two groups. The percentage of patinents with high GRACE scores (>140) were 53% in the worsening group versus 34% in the without worsening group (p¼0.012). Mean value of baseline eGFR was lower in the worsening group (65Æ26 vs 76Æ24 ml/min./ 1.73m2, p¼0.001). Patients with worsening renal function were more often of multi vessels disease (three vessels disease 27% vs 19%, p¼0.021). Thirty-day all cause mortality rates were 17% in the wors- ening group versus 4.1% in the without worsening group (p<0.0001). Worsening renal function was identified as an independent predictor of thirty-day mortality after multivariate analysis including significant variables in univariate analysis ( odds ratio¼3.395, 95% CI 1.257- 9.175, p¼0.016). Conclusion: In the setting of NSTE-MI, worsening renal function during the hospital stay is associated with increased thirty-day mortality, independent of other conventional risk factors. - PP-061 Coronary Aneurysm after Bioresorbable Vascular Scaffold Implantation. Ejder Kardes ¸o glu, Murat Yalçın , Ömer Yi giner, Bekir Sıtkı Cebeci. Gulhane Military Medical Academy, Haydarpasa Hospital, Department Of Cardiology, Istanbul/Turkey. Coronary artery aneurysm is a rare complication tha tmay be occurred after bare and drug-eluting stent implantation. Although some etiologic factors such as inflammation, hypersensitivity, drugtoxicity, vessel wall injury etc. have been proposed, its mechanism remains unclear. Bioresorbable stents opened a new era in interventional car- diology. The everolimus eluting Bioresorbable Vascular Scaffold (BVS) (AbbottVascular) is being tested currently in many studies with regard to its efficacy and safety. However, there are still many questions be answered. The risk of coronary aneurysm and late strut malap- position is theoretically possible after the BVS implantation. Herein, we presented a case of developing coronary aneurysm after one year from the BVS implantation. Case: 59 years-old male patient. His risk factors were diabetes, hy- pertension and smoking. He had been undergone coronary angiography after a stress test. There had been no significant disease in the right and circumflex coronary arteries. It had showed an intermediate stenosis in the midportion and a 70-80 % of tubularstenosis in the mid-distal portion of the left anterior decending artery (LAD). After coronary hemodynamic study with a pressure wire, a 2.5 x28 mm BVS has been implanted at the tubular stenosis in the mid-distalportion of the LAD following well predilation with a 2.5x20 NC baloon. A satisfactory result has been achieved after postdilation (Figure 1A). In his last control after one year, he suffered from stable angina for one month. The patient underwent control coronary angiography. We identified the formation of a small aneurysm in the middle part of the BVS (Figure 1B). Othe rfindings were almost the same with those of previous angiography. We performed the IVUS examination. In the distal part, the struts and the growing tissue between struts were clearly identifiable (Figure 2d). In the middle and proximal parts, some struts within the tissue could be seen (Figure 2a). It showed the development of aneu- rysm with relatively thinner vessel wall between 12 and 5 o’clock in the midpart of the BVS. In this region, we detected only one strut malap- position (Figure 2b and 2c). The patient has been followed medically. Baseline Characteristics Variable Patient with worsening renal function Patient without worsening renal function p value n¼47 n¼340 Gender (% male) 72% 66% 0.400 Mean age (year) 67Æ12 63Æ13 0.032 History of diabetes 40% 36% 0.544 History of hypertension 81% 71% 0.143 Smoking 17% 27% 0.151 Hypercholesterolemia 23% 27% 0.823 History of CHF 9% 9% 0.842 History of CVD 15% 7% 0.040 History of CAD 43% 46% 0.667 Killip II-IV 21% 13% 0.107 Mean eGFR ml/mn./1.73m2 65Æ26 76Æ24 0.001 Mean GRACE score 141Æ38 127Æ36 0.010 CAG 64% 72% 0.262 3 vessels disease 27% 19% 0.021 PCI 17% 30% 0.059 CABG 32% 12% <0.001 Data are presented as the percentage of subjects or mean value SD, unless otherwise indicated. CABG coronary artery bypass graft surgery; CHF congestive heart failure; PCI percutaneous coronary intervention; CAG coronary angiography; CVD cerebrovascular disease; eGFR estimated glomerular filtration rate. MARCH 26e29, 2015 S124 The American Journal of Cardiology â MARCH 26e29, 2015 11 th INTERNATIONAL CONGRESS OF UPDATE IN CARDIOLOGY AND CARDIOVASCULAR SURGERY ABSTRACTS / Poster P O S T E R A B S T R A C T S